204 related articles for article (PubMed ID: 37660103)
1. Structure-based design of a strain transcending AMA1-RON2L malaria vaccine.
Patel PN; Dickey TH; Diouf A; Salinas ND; McAleese H; Ouahes T; Long CA; Miura K; Lambert LE; Tolia NH
Nat Commun; 2023 Sep; 14(1):5345. PubMed ID: 37660103
[TBL] [Abstract][Full Text] [Related]
2. Structure guided mimicry of an essential P. falciparum receptor-ligand complex enhances cross neutralizing antibodies.
Yanik S; Venkatesh V; Parker ML; Ramaswamy R; Diouf A; Sarkar D; Miura K; Long CA; Boulanger MJ; Srinivasan P
Nat Commun; 2023 Sep; 14(1):5879. PubMed ID: 37735574
[TBL] [Abstract][Full Text] [Related]
3. A malaria vaccine protects
Srinivasan P; Baldeviano GC; Miura K; Diouf A; Ventocilla JA; Leiva KP; Lugo-Roman L; Lucas C; Orr-Gonzalez S; Zhu D; Villasante E; Soisson L; Narum DL; Pierce SK; Long CA; Diggs C; Duffy PE; Lescano AG; Miller LH
NPJ Vaccines; 2017; 2():. PubMed ID: 28804644
[TBL] [Abstract][Full Text] [Related]
4. Characterization of AMA1-RON2L complex with native gel electrophoresis and capillary isoelectric focusing.
Zhu D; Dai W; Srinivasan P; McClellan H; Braden D; Allee-Munoz A; Hurtado PAG; Miller LH; Duffy PE
Electrophoresis; 2022 Feb; 43(3):509-515. PubMed ID: 34679212
[TBL] [Abstract][Full Text] [Related]
5. Structure guided mimicry of an essential P. falciparum receptor-ligand complex enhances cross neutralizing antibodies.
Srinivasan P; Yanik S; Venkatesh V; Parker M; Diouf A; Sarkar D; Miura K; Long C; Boulanger M
Res Sq; 2023 Apr; ():. PubMed ID: 37131813
[TBL] [Abstract][Full Text] [Related]
6. Bliss' and Loewe's additive and synergistic effects in Plasmodium falciparum growth inhibition by AMA1-RON2L, RH5, RIPR and CyRPA antibody combinations.
Azasi Y; Gallagher SK; Diouf A; Dabbs RA; Jin J; Mian SY; Narum DL; Long CA; Gaur D; Draper SJ; Fay MP; Miller LH; Miura K
Sci Rep; 2020 Jul; 10(1):11802. PubMed ID: 32678144
[TBL] [Abstract][Full Text] [Related]
7. Overcoming antigenic diversity by enhancing the immunogenicity of conserved epitopes on the malaria vaccine candidate apical membrane antigen-1.
Dutta S; Dlugosz LS; Drew DR; Ge X; Ababacar D; Rovira YI; Moch JK; Shi M; Long CA; Foley M; Beeson JG; Anders RF; Miura K; Haynes JD; Batchelor AH
PLoS Pathog; 2013; 9(12):e1003840. PubMed ID: 24385910
[TBL] [Abstract][Full Text] [Related]
8. Immunization with a functional protein complex required for erythrocyte invasion protects against lethal malaria.
Srinivasan P; Ekanem E; Diouf A; Tonkin ML; Miura K; Boulanger MJ; Long CA; Narum DL; Miller LH
Proc Natl Acad Sci U S A; 2014 Jul; 111(28):10311-6. PubMed ID: 24958881
[TBL] [Abstract][Full Text] [Related]
9. Identification of a potent combination of key Plasmodium falciparum merozoite antigens that elicit strain-transcending parasite-neutralizing antibodies.
Pandey AK; Reddy KS; Sahar T; Gupta S; Singh H; Reddy EJ; Asad M; Siddiqui FA; Gupta P; Singh B; More KR; Mohmmed A; Chitnis CE; Chauhan VS; Gaur D
Infect Immun; 2013 Feb; 81(2):441-51. PubMed ID: 23184525
[TBL] [Abstract][Full Text] [Related]
10. Passive immunization with a multicomponent vaccine against conserved domains of apical membrane antigen 1 and 235-kilodalton rhoptry proteins protects mice against Plasmodium yoelii blood-stage challenge infection.
Narum DL; Ogun SA; Batchelor AH; Holder AA
Infect Immun; 2006 Oct; 74(10):5529-36. PubMed ID: 16988228
[TBL] [Abstract][Full Text] [Related]
11. Humoral immune response to mixed PfAMA1 alleles; multivalent PfAMA1 vaccines induce broad specificity.
Kusi KA; Faber BW; Thomas AW; Remarque EJ
PLoS One; 2009 Dec; 4(12):e8110. PubMed ID: 19956619
[TBL] [Abstract][Full Text] [Related]
12. Defining species-specific and conserved interactions of apical membrane protein 1 during erythrocyte invasion in malaria to inform multi-species vaccines.
Drew DR; Wilson DW; Weiss GE; Yeoh LM; G Henshall I; Crabb BS; Dutta S; Gilson PR; Beeson JG
Cell Mol Life Sci; 2023 Feb; 80(3):74. PubMed ID: 36847896
[TBL] [Abstract][Full Text] [Related]
13. Strain-transcending neutralization of malaria parasite by antibodies against Plasmodium falciparum enolase.
Dutta S; Tewari A; Balaji C; Verma R; Moitra A; Yadav M; Agrawal P; Sahal D; Jarori GK
Malar J; 2018 Aug; 17(1):304. PubMed ID: 30126436
[TBL] [Abstract][Full Text] [Related]
14. Defining the antigenic diversity of Plasmodium falciparum apical membrane antigen 1 and the requirements for a multi-allele vaccine against malaria.
Drew DR; Hodder AN; Wilson DW; Foley M; Mueller I; Siba PM; Dent AE; Cowman AF; Beeson JG
PLoS One; 2012; 7(12):e51023. PubMed ID: 23227229
[TBL] [Abstract][Full Text] [Related]
15. Plasmodium berghei circumvents immune responses induced by merozoite surface protein 1- and apical membrane antigen 1-based vaccines.
Yoshida S; Nagumo H; Yokomine T; Araki H; Suzuki A; Matsuoka H
PLoS One; 2010 Oct; 5(10):e13727. PubMed ID: 21060850
[TBL] [Abstract][Full Text] [Related]
16. In vitro studies with recombinant Plasmodium falciparum apical membrane antigen 1 (AMA1): production and activity of an AMA1 vaccine and generation of a multiallelic response.
Kennedy MC; Wang J; Zhang Y; Miles AP; Chitsaz F; Saul A; Long CA; Miller LH; Stowers AW
Infect Immun; 2002 Dec; 70(12):6948-60. PubMed ID: 12438374
[TBL] [Abstract][Full Text] [Related]
17. Isolation and light chain shuffling of a Plasmodium falciparum AMA1-specific human monoclonal antibody with growth inhibitory activity.
Seidel-Greven M; Addai-Mensah O; Spiegel H; Chiegoua Dipah GN; Schmitz S; Breuer G; Frempong M; Reimann A; Klockenbring T; Fischer R; Barth S; Fendel R
Malar J; 2021 Jan; 20(1):37. PubMed ID: 33430886
[TBL] [Abstract][Full Text] [Related]
18. High antibody titer against apical membrane antigen-1 is required to protect against malaria in the Aotus model.
Dutta S; Sullivan JS; Grady KK; Haynes JD; Komisar J; Batchelor AH; Soisson L; Diggs CL; Heppner DG; Lanar DE; Collins WE; Barnwell JW
PLoS One; 2009 Dec; 4(12):e8138. PubMed ID: 19997632
[TBL] [Abstract][Full Text] [Related]
19. Bacterially expressed full-length recombinant Plasmodium falciparum RH5 protein binds erythrocytes and elicits potent strain-transcending parasite-neutralizing antibodies.
Reddy KS; Pandey AK; Singh H; Sahar T; Emmanuel A; Chitnis CE; Chauhan VS; Gaur D
Infect Immun; 2014 Jan; 82(1):152-64. PubMed ID: 24126527
[TBL] [Abstract][Full Text] [Related]
20. Antibodies to polymorphic invasion-inhibitory and non-Inhibitory epitopes of Plasmodium falciparum apical membrane antigen 1 in human malaria.
Mugyenyi CK; Elliott SR; McCallum FJ; Anders RF; Marsh K; Beeson JG
PLoS One; 2013; 8(7):e68304. PubMed ID: 23861883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
